The role of CRF receptor subtypes in stress-induced behavioural responses

European Journal of Pharmacology

Volumn 405, Issue 1-3, 2000, Pages 199-206

  Smagin, Gennady N ^a   Dunn, Adrian J ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

(Antagonist); Antisense; Behaviour; CRF (corticotropin releasing factor); CRF receptor; Stress; Urocortin

Indexed keywords

ANTALARMIN; ANTISAUVAGINE 30; ANTISENSE OLIGONUCLEOTIDE; ASTRESSIN; BUTYL[2,5 DIMETHYL 7 (2,4,6 TRIMETHYLPHENYL) 7H PYRROLO[2,3 D]PYRIMIDIN 4 YL]ETHYLAMINE; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR 1 RECEPTOR; CORTICOTROPIN RELEASING FACTOR 2 RECEPTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR DERIVATIVE; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CORTICOTROPIN RELEASING FACTOR[9-41]; CRA 1000; NB 127914; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

BEHAVIOR; CONFERENCE PAPER; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; RECEPTOR BINDING; STRESS; TISSUE DISTRIBUTION; TRANSGENIC MOUSE;

AMINO ACID SEQUENCE; ANIMAL; BEHAVIOR; BEHAVIOR, ANIMAL; COMPARATIVE STUDY; HUMAN; MOLECULAR SEQUENCE DATA; RATS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; STRESS, PSYCHOLOGICAL;

EID: 0034730480     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00553-7     Document Type: Conference Paper

References (75)

1. Neurobiology of corticotropin-releasing factor (CRF) receptors and CRF-binding protein: implications for the treatment of CNS disorders
2. Corticotropin releasing factor (CRF) receptor antagonist blocks activating and 'anxiogenic' actions of CRF in the rat
3. 1 receptor mRNA expression
4. Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain
5. Design and synthesis of a series of non-peptide high-affinity human corticotropin-releasing factor-1 receptor antagonists
6. Expression cloning of a human corticotropin-releasing-factor receptor
7. Activation of the locus coeruleus noradrenergic system by intracoerulear microinfusion of corticotropin-releasing factor: effects on discharge rate, cortical norepinephrine levels and cortical electroencephalographic activity
8. Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders
9. The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress
10. Cloning and characterization of human urocortin
11. Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?
12. Behavioral responses to stress are intact in CRF-deficient mice
13. 2) messenger ribonucleic acid levels in the hypothalamic ventromedial nucleus of the infant rat are reduced by maternal deprivation
14. 2) in rat brain predicts distinct age-specific functions
15. 3H]-urocortin
16. Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone
17. 0-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2α receptors
18. Potent, structurally constrained agonists and competitive antagonists of corticotropin-releasing factor
19. Corticotropin-releasing factor modulates dietary preference in nutritionally and physically stressed rats
20. Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action
21. The role of corticotropin-releasing factor and urocortin in the modulation of ingestive behavior
22. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety
23. Urocortin messenger ribonucleic acid: tissue distribution in the rat and regulation in thymus by lipopolysaccharide and glucocorticoids
24. Corticotropin-releasing factor and behavior
25. The role of corticotropin-releasing factor in behavioural responses to stress
26. Distribution of urocortin-like immunoreactivity in the central nervous system of the rat
27. Role of cyclo-oxygenase pathways in the stimulatory influence of immune challenge on the transcription of a specific CRF receptor subtype in the rat brain
28. Alcohol increases the expression of type 1, but not type 2 alpha corticotropin-releasing factor (CRF) receptor messenger ribonucleic acid in the rat hypothalamus
29. Intra-amygdala injections of corticotropin releasing factor facilitate inhibitory avoidance learning and reduce exploratory behavior in rats
30. Differential behavioral effects of chronic infusion of CRH1 and CRH2 receptor antisense oligonucleotides into the rat brain
31. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain
32. CRF2α and CRF2β receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues
33. A non peptidic corticotropin releasing factor receptor antagonist attenuates fever and exhibits anxiolytic-like activity
34. Altered expression of type 2 CRH receptor mRNA in the VMH by glucocorticoids and starvation
35. 1 receptor antagonist
36. Regulation of corticotropin-releasing factor type 1 (CRF1) receptor messenger ribonucleic acid in the paraventricular nucleus of rat hypothalamus by exogenous CRF
37. Corticotropin-releasing factor but not urocortin is involved in adrenalectomy-induced adrenocorticotropin release
38. Immunocytochemical localization of corticotropin releasing factor (CRF) in the rat spinal cord
39. Corticotropin releasing factor (CRF): origin and course of afferent pathways to the median eminence (ME) of the rat hypothalamus
40. Immunocytochemical localization of corticotropin-releasing factor (CRF) in the rat brain
41. Urocortin, a novel neuropeptide with anxiogenic-like properties
42. Differential distribution of urocortin-and corticotropin-releasing factor-like immunoreactivities in the rat brain
43. Receptor binding, behavioral, and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001
44. Physiology and pharmacology of corticotropin-releasing factor
45. Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor
46. 2 binding sites in adult rat brain
47. Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2
48. Synthetic competitive antagonists of corticotropin-releasing factor: effect on ACTH secretion in the rat
49. 2 receptors: membrane homogenate and autoradiographic studies
50. Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): development of CRFR2β-selective antisauvagine-30
51. Corticotropin releasing factor-like immunoreactivity in the rat brain as revealed by a modified cobalt-glucose oxidase-diaminobenzidine method
52. Autoradiographic and in situ hybridization localization of corticotropin-releasing factor 1 and 2 receptors in nonhuman brain
53. Localization, colocalization, and plasticity of corticotropin-releasing factor immunoreactivity in rat brain
54. Organization of CRF immunoreactive cells and fibers in the rat brain: immunohistochemical studies
55. Centrally administered oligodeoxynucleotides in rats: occurence of non-specific effects
56. CP-154,526: a potent and selective nonpeptide antagonist of corticotropin-releasing factor receptors
57. The role of CRF2 receptors in corticotropin-releasing factor- and urocortin-induced anorexia
58. The role of CRF1 receptors in restraint-, CRF- and urocortin-induced anxiety-like behaviors
59. Corticotropin-releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response and aberrant neuroendocrine development
60. Corticotropin-releasing hormone receptor subtypes and emotion
61. Corticotropin releasing factor produces behavioural activation in rats
62. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study
63. CRF-deficient mice respond like wild-type mice to hypophagic stimuli
64. Functional activation of CRH neurons and expression of the genes encoding CRH and its receptors in food-deprived lean (Fa/?) and obese (fa/fa) Zucker rats
65. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1
66. Urocortin is not a significant regulator of intermittent electrofootshock-induced adrenocorticotropin secretion in the intact male rat
67. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin
68. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor
69. In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation
70. Stress-induced behaviors require the corticotropin-releasing hormone (CRH) receptor, but not CRH
71. Urocortin expression in the Edinger-Westphal nucleus is up-regulated by stress and corticotropin-releasing hormone deficiency
72. Localization of urocortin messenger RNA in rat brain and pituitary
73. Urocortin-like immunoreactivity in the substantia nigra, ventral tegmental area and Edinger-Westphal nucleus of rat
74. The distribution of urocortin-like immunoreactivity in the central nervous system of the rat